| abstract |
Use is disclosed of non-β-oxidizable fatty acidsnanalogues of the general formula (I)n Alkyl-X-CH 2 COOR nwherein alkyl represents a saturated or unsaturatednhydrocarbon group of from 8-26 carbon atoms, X representsna sulphur atom and R is hydrogen or C 1 -C 4 alkyl, for thenmanufacture of a medicament to inhibit the oxidativenmodification of low density lipoprotein (LDL). |